MDA: Misuse of Drugs Act 1971
The Misuse of Drugs Act (MDA) was introduced in the UK in 1971 and categorised drugs into different schedules depending on their potential to be dangerous or hazardous to health.
Under part II, Schedule 2 of the Misuse of Drugs Act 1971, cannabis is still classed as a Class B drug that is illegal to possess, supply, produce, import and export without approval from the Home Office.
However, since the legalisation of medical cannabis in 2018, prescribing doctors can lawfully prescribe CBMP without a home office licence, but businesses involved in the supply chain of cannabis still need Home Office approval.
What constitutes a Class B drug in the UK?
Class B drugs under the Misuse of Drugs Act are substances that are considered to have a high potential for abuse and harmful effects on an individual's physical or mental health. These include amphetamines, barbiturates, codeine, ketamine, synthetic cannabinoid receptor agonists, and synthetic opioids.
What are the consequences of being caught in possession of a Class B drug?
If someone is caught in possession of a Class B drug in the UK, they can face up to 5 years in prison, an unlimited fine, or both. The severity of the consequences depends on the circumstances and the individual's criminal history.
Do medical cannabis patients in the UK have to worry about prosecution?
No, as long as the patient has been prescribed medical cannabis by a specialist listed on the General Medical Council's Specialist Register, they will not face prosecution. It is advised that patients always carry their prescribed cannabis in the original packaging with a label showing their name and the prescribing specialist's name, as well as a copy of their prescription.
It is still illegal for individuals to possess cannabis without a prescription or supply it to others illegally.
To find out more about the Misuse of Drugs Act click here.
If you would like to learn more about medical cannabis in the UK, Releaf is here to help.